These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32540820)

  • 41. Combination Cisplatin-Epirubicin-Paclitaxel Therapy for Metastatic Extramammary Paget's Disease.
    Hirai I; Tanese K; Nakamura Y; Ishii M; Kawakami Y; Funakoshi T
    Oncologist; 2019 Jun; 24(6):e394-e396. PubMed ID: 30846514
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of S-1 plus docetaxel in the treatment of metastatic extramammary Paget's disease: a multicentre retrospective study.
    Matsushita S; Fujii K; Kajihara I; Aoki M; Yamamura K; Tada K; Kanekura T; Aoi J; Fukushima S
    Br J Dermatol; 2021 Aug; 185(2):458-460. PubMed ID: 33829494
    [No Abstract]   [Full Text] [Related]  

  • 43. Low-dose 5-fluorouracil/cisplatin therapy as conversion chemotherapy for advanced extramammary Paget's disease.
    Nakamura K; Nakamura M; Kato H; Morita A
    Kaohsiung J Med Sci; 2020 Apr; 36(4):287-288. PubMed ID: 31868989
    [No Abstract]   [Full Text] [Related]  

  • 44. [Chemotherapy of advanced adenocarcinoma of the skin].
    Yamazaki N
    Gan To Kagaku Ryoho; 1993 Aug; 20(10):1302-7. PubMed ID: 8394060
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Docetaxel, cisplatin and S-1 (DCS) combination chemotherapy for gastric cancer patients with peritoneal metastasis: a retrospective study.
    Ohnuma H; Sato Y; Hirakawa M; Kikuchi S; Miyanishi K; Sagawa T; Takahashi Y; Nobuoka T; Okamoto K; Miyamoto H; Takemasa I; Takayama T; Kato J
    Cancer Chemother Pharmacol; 2018 Mar; 81(3):539-548. PubMed ID: 29383482
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of limited extent extramammary Paget's disease with 5 percent imiquimod cream.
    Badgwell C; Rosen T
    Dermatol Online J; 2006 Jan; 12(1):22. PubMed ID: 16638390
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of primary extramammary Paget's disease of the perineum with topical imiquimod 5% cream.
    Dias Coelho J; Vale E; Viana I; Martins O
    Eur J Dermatol; 2010; 20(4):532-3. PubMed ID: 20566431
    [No Abstract]   [Full Text] [Related]  

  • 48. A Multicenter Randomized Phase II Study of Docetaxel vs. Docetaxel Plus Cisplatin vs. Docetaxel Plus S-1 as Second-Line Chemotherapy in Metastatic Gastric Cancer Patients Who Had Progressed after Cisplatin Plus Either S-1 or Capecitabine.
    Lee KW; Kim BJ; Kim MJ; Han HS; Kim JW; Park YI; Park SR
    Cancer Res Treat; 2017 Jul; 49(3):706-716. PubMed ID: 27764906
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phase II study of docetaxel, oxaliplatin, and S-1 therapy in patients with metastatic gastric cancer.
    Kim HS; Ryu MH; Zang DY; Ryoo BY; Yang DH; Cho JW; Lim MS; Kim MJ; Han B; Choi DR; Kim JH; Jung JY; Song H; Park CK; Kang YK
    Gastric Cancer; 2016 Apr; 19(2):579-585. PubMed ID: 25997815
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of double ectopic extramammary Paget's disease of bilateral chest with imiquimod 5% cream.
    Yeh MH; Hu SL
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):997-9. PubMed ID: 17659025
    [No Abstract]   [Full Text] [Related]  

  • 51. [Docetaxel plus S-1 as a second-line chemotherapy for metastasis or recurrence of esophageal cancer].
    Nakamura T; Ota M; Narumiya K; Sato T; Shirai Y; Yamamoto M; Kuramochi H; Hayashi K
    Gan To Kagaku Ryoho; 2012 Feb; 39(2):227-30. PubMed ID: 22333632
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Salvage therapy for castration-refractory prostate cancer resistant to docetaxel].
    Takayama T; Sugiyama T; Furuse H; Yajima T; Suzuki T; Kai F; Nagata M; Otsuka A; Ishii Y; Ozono S
    Nihon Hinyokika Gakkai Zasshi; 2013 Nov; 104(6):681-7. PubMed ID: 24564074
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Photodynamic therapy with methyl-aminolevulinate for the treatment of double extramammary Paget's disease.
    Kitagawa KH; Bogner P; Zeitouni NC
    Dermatol Surg; 2011 Jul; 37(7):1043-6. PubMed ID: 21631634
    [No Abstract]   [Full Text] [Related]  

  • 54. A phase II study of perioperative S-1 combined with weekly docetaxel in patients with locally advanced gastric carcinoma: clinical outcomes and clinicopathological and pharmacogenetic predictors for survival.
    Kim YW; Kim MJ; Ryu KW; Lim HS; Lee JH; Kong SY; Lee JS; Choi IJ; Kim CG; Lee JY; Cho SJ; Kook MC; Park YI; Kim SK; Park SR
    Gastric Cancer; 2016 Apr; 19(2):586-596. PubMed ID: 25851942
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mammary and extramammary Paget's disease.
    Sitakalin C; Ackerman AB
    Am J Dermatopathol; 1985 Aug; 7(4):335-40. PubMed ID: 3026195
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of subsequent docetaxel +/- ramucirumab and S-1 after nivolumab for patients with advanced non-small cell lung cancer.
    Tamura N; Horinouchi H; Sekine K; Matsumoto Y; Murakami S; Goto Y; Kanda S; Fujiwara Y; Yamamoto N; Ohe Y
    Thorac Cancer; 2019 May; 10(5):1141-1148. PubMed ID: 30913364
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Letter: Photodynamic therapy with methyl-aminolevulinate for the treatment of double extramammary Paget's disease.
    Longo-Imedio MI
    Dermatol Surg; 2013 Jan; 39(1 Pt 1):144-5. PubMed ID: 23301787
    [No Abstract]   [Full Text] [Related]  

  • 58. A dose-escalation study of docetaxel, oxaliplatin, and S-1 (DOS) as a first-line therapy for patients with unresectable metastatic gastric cancer.
    Sato Y; Sagawa T; Ohnuma H; Hirakawa M; Takahashi Y; Hamaguchi K; Fujikawa K; Nobuoka T; Okamoto K; Miyamoto H; Muguruma N; Takemasa I; Takayama T
    Cancer Chemother Pharmacol; 2019 Jan; 83(1):161-167. PubMed ID: 30406285
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Trial of low-dose 5-fluorouracil/cisplatin therapy for advanced extramammary Paget's disease.
    Kariya K; Tsuji T; Schwartz RA
    Dermatol Surg; 2004 Feb; 30(2 Pt 2):341-4. PubMed ID: 14871231
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Efficacy and safety of S-1 plus docetaxel combination therapy for patients with advanced gastric cancer].
    Nishiwaki H; Yamada T; Tachi K; Iwasaki H; Hori Y; Umemura S; Yamakawa Y; Kurimoto T; Ban T; Fujiwara K; Hayashi K; Nemoto A; Shiroko J; Orito E
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1663-6. PubMed ID: 19838024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.